 Wysłany: Pon 21:00, 07 Mar 2011 Temat postu: adidas scarpe tdt drx kugl xiw |
|
| Sodium selenite K562/ADR VEGF expression in cell lines
yelodysplasticsyndromes. Cancer ,2002:95:1923-19308de-BontES, FidlerV, MeeuwsenT, eta1. Vascularendothelialgrowthfactorsecretionisanindependentprognosticfactorforrelapse-freesurvivalinpediatricacutemyeloidleukemiapatients. ClinCanc-erRes, 2002; 8:2856-28619 Guozong Ming, Xie Zhaoxia, Qin Yi. VEGF in patients with acute leukemia and multidrug resistance relations discussed. Chinese Medical Journal, 2004; 5:121-12310ZhuZ, HattoriK, ZhangH, eta1. Inhibitionofhumanleukemiainananimalmodelwithhumanantibodiesdirectedagainstvascularen-dothelialgrowthfactorreceptor2. Correlationbetweenantibodyaffin. ityandbiologicalactivity. Leukemia, 2003; 17:6 O4-61111KatohO,adidas scarpe, TakahashiT, OguriT, eta1. Vascularendothelialgrowthfactorinhibitsapoptoticdeathinhematopoieticcellsafterexposuretochem0therapeuticdrugsbyinducingMCL1actingasanantiapoptoticfactor. CancerRes,mbt shoes utlet, 1998; 58:5565-556912DiasS, ShmelkovSV, LamG,ghd italia, eta1. VEGF (165) promotessurvivalofleukemiccellsbyHsp90. . mediatedinductionofBc1. . 2expressionandapoptosisinhibition. Blood, 2002; 99:2532-254013 Wang, Fang-Yuan Chen, s Entry and so on. ATRA and DNR on NB4 and HL-60 cell line expression and secretion of VEGF. Chinese Journal of Hematology, 2004; 25:171-17414HeR, LiuB, YangC, eta1. InhibitionofK562leukemiaangiogen-esisandgrowthbyexpressionofantisensevascularendothelialgrowthfactor (VEGF) sequence. CancerGeneTher, 2003; 10:879-88615Le-GouillS, PodarK. AmiotM. eta1. VEGFinducesMc1.1up. reg. ulationandprotectsmultiplemyelomacellsagainstapoptosis. Blood,tory burch reva, 2004; 104:2886-289216RuanGR, LiuYR, ChenSS. eta1. EffectofantisenseVEGFcDNAtransfectiononthegrowthofchronicmyeloidleukemiaK562cellsinvitroandinnudemice. LeukRes ,2004:28:763-76917 Ye Jin, Liu Fu-Qiang,belstaff espana, Wu Yi Ping. All-trans retinoic acid and sodium selenite on HL-60 cells expression of VEGF and its receptor. Journal of Experimental Hematology, 2004; 12:142-146 |
|
